Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1996
10/15/1996US5565204 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
10/14/1996CA2174025A1 Agents modulating the response of neuronal cells to inhibition by mammalian central nervous system myelin
10/10/1996WO1996031780A1 Reagents and methods for the detection and quantification of vancomycin in biological fluids
10/10/1996WO1996031618A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
10/10/1996WO1996031613A1 Expression library immunization
10/10/1996WO1996031607A2 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
10/10/1996WO1996031605A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996WO1996031604A1 Antibodies for the detection of hla-g
10/10/1996WO1996031602A1 Retroviral vectors
10/10/1996WO1996031601A1 Polynucleotide immunogenic agents
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031539A1 Antibodies and their use in cancer therapy and diagnosis
10/10/1996WO1996031538A1 Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker
10/10/1996WO1996031526A1 Anti-obesity agents
10/10/1996WO1996031224A1 Immunosuppressant
10/10/1996WO1996031186A2 Product and method for preventing respiratory virus infection
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996CA2217697A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996CA2217491A1 Polynucleotide immunogenic agents
10/10/1996CA2217450A1 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses
10/10/1996CA2216880A1 Reagents and methods for the detection and quantification of vancomycin in biological fluids
10/10/1996CA2216092A1 Expression library immunization
10/10/1996CA2213620A1 Antibodies for the detection of hla-g
10/10/1996CA2212562A1 Product and method for preventing respiratory virus infection
10/09/1996EP0736770A2 An immunoreactive conjugate, method for its preparation, antibodies to said conjugate and a pharmaceutical composition and diagnostic device containing them
10/09/1996EP0736601A2 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
10/09/1996EP0736544A1 Oral care compositions
10/09/1996EP0736543A2 Method for the production of monoclonal antibodies to proliferation-associated antigens of the cell nucleus
10/09/1996EP0736542A1 Peptides that induce antibodies which inhibit HIV-type retroviruses and antibodies specific for these peptides
10/09/1996EP0736302A2 Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors
10/09/1996EP0736106A1 Methods of screening for beta-amyloid peptide production inhibitors
10/09/1996EP0736094A1 Polycystic kidney disease 1 gene and uses thereof
10/09/1996EP0736088A1 Monoclonal antibodies to hepatitis e virus and methods for using same
10/09/1996EP0736087A1 Monoclonal antibodies against hev orf-2 and methods for using same
10/09/1996EP0736042A1 Markers of organ rejection
10/09/1996EP0736034A1 Dna encoding the wnt-x growth factor
10/09/1996EP0735895A1 A method for preventing or controlling cataract
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735889A1 A novel tumor suppressor gene
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0648123B1 INHIBITORS OF PROTEIN TYROSINE-PHOSPHATASE $g(a) FOR TREATMENT OF TUMORS
10/09/1996EP0528928B1 Interleukin-4 binding protein-gamma
10/09/1996CN1133050A Composition and methods using nitroxides to avoid oxygen toxicity
10/08/1996US5563247 Complexing
10/08/1996US5563123 Chimeric proteins
10/08/1996US5563074 Immunological detection methods
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/08/1996US5562907 Method to prevent side-effects and insensitivity to the therapeutic uses of toxins
10/08/1996US5562905 Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
10/08/1996US5562904 Retroviral transduction of cells using soluble complement inhibitors
10/08/1996US5562903 Humanized antibodies that recognize difucosyl Lewis blood group antigens Y-6 and B-7-2
10/08/1996US5562902 Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
10/07/1996CA2170073A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
10/03/1996WO1996030765A1 Assaying protein fragments in body fluids
10/03/1996WO1996030520A2 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
10/03/1996WO1996030519A1 Haemophilus adhesion proteins
10/03/1996WO1996030517A1 Genetic sequences conferring nematode resistance in plants and uses therefor
10/03/1996WO1996030516A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/03/1996WO1996030512A1 Conditional expression system
10/03/1996WO1996030511A1 Polymorphic and multicopy members of mhc gene families
10/03/1996WO1996030506A1 Antibody to human betacellulin and use thereof
10/03/1996WO1996030504A1 Modified viral envelope polypeptide
10/03/1996WO1996030498A1 Production of antibodies using cre-mediated site-specific recombination
10/03/1996WO1996030494A1 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies
10/03/1996WO1996030408A1 Antibody to the syncytiotrophoblast antigen r80k and use thereof
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030400A1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES
10/03/1996WO1996030057A1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
10/03/1996WO1996030047A1 Immunotargeting of plasminogen activators to the pulmonary endothelium
10/03/1996WO1996030046A1 Vascular endothelial cell growth factor antagonists
10/03/1996WO1996030043A1 Treatment for verotoxin-producing escherichia coli
10/03/1996WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996WO1996022373A3 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
10/03/1996CA2805588A1 Vascular endothelial cell growth factor antagonists
10/03/1996CA2754887A1 Vascular endothelial cell growth factor antagonists
10/03/1996CA2218601A1 Treatment for verotoxin-producing escherichia coli
10/03/1996CA2217009A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996CA2216835A1 Human g-protein coupled receptors
10/03/1996CA2216799A1 Genetic sequences conferring nematode resistance in plants and uses therefor
10/03/1996CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2216292A1 Haemophilus adhesion proteins
10/03/1996CA2215355A1 Antibody, hybridoma and use thereof
10/03/1996CA2214451A1 Conditional expression system
10/03/1996CA2191774A1 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies
10/02/1996EP0735370A1 Method for assaying map kinase
10/02/1996EP0734529A1 Methods and materials for the detection of staphylococcus aureus
10/02/1996EP0734526A1 Maleimide adduct conjugates of procainamide and napa
10/02/1996EP0734451A1 ENTEROTOXINS OF $i(SHIGELLA FLEXNERI) 2a
10/02/1996EP0734442A1 Diagnosis of metastatic cancer by the mts-1 gene
10/02/1996EP0734436A1 Inhibition of dna methyltransferase
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/02/1996EP0734263A1 ALPHAvBETA3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS
10/02/1996EP0670849A4 Diagnostic assay for latent matrix metalloproteinase no. 9.
10/02/1996EP0575497B1 Dna sequences which code for virulence characteristics of -$(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by -$(s. suis) in mammals, including man
10/02/1996EP0487621B1 Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated n-terminal amino acids
10/02/1996EP0487617B1 Synthetic peptides that enhance cell binding
10/02/1996CN1132516A Monoclonal IgA antibody against respiratory syncytial virus
10/02/1996CN1132514A Protective antigens against parasites
10/01/1996US5561223 DCC protein
1 ... 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 ... 1494